Leishmaniasis is a serious parasitic disease caused by Leishmania species transmitted by the bite of sandflies. This disease is also an important public health problem. Clinical manifestations can be classified as cut...Leishmaniasis is a serious parasitic disease caused by Leishmania species transmitted by the bite of sandflies. This disease is also an important public health problem. Clinical manifestations can be classified as cutaneous, mucocutaneous, and visceral leishmaniasis, depending on the species of parasite and the host’s immune status. Although the cutaneous form is not fatal, it often causes disfiguring scars on the skin[1].展开更多
Hepatitis C virus (HCV) infection is a global health problem. HCV is one of the leading causes for acute and chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. The prevalence of HCV infection varies f...Hepatitis C virus (HCV) infection is a global health problem. HCV is one of the leading causes for acute and chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. The prevalence of HCV infection varies from 0. 1% to 0. 2% in the West, to 3% in Mediterranean countries and up to 6% in tropical areas. The prevalence in Turkey is about 1.8%. HCV is classified into six different genotypes (genotypes 1 -6 ), each consisting of different subtypes. HCV genotypes and their subtypes coexist in various geographic locations but show different prevalence levels.展开更多
文摘Leishmaniasis is a serious parasitic disease caused by Leishmania species transmitted by the bite of sandflies. This disease is also an important public health problem. Clinical manifestations can be classified as cutaneous, mucocutaneous, and visceral leishmaniasis, depending on the species of parasite and the host’s immune status. Although the cutaneous form is not fatal, it often causes disfiguring scars on the skin[1].
文摘Hepatitis C virus (HCV) infection is a global health problem. HCV is one of the leading causes for acute and chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. The prevalence of HCV infection varies from 0. 1% to 0. 2% in the West, to 3% in Mediterranean countries and up to 6% in tropical areas. The prevalence in Turkey is about 1.8%. HCV is classified into six different genotypes (genotypes 1 -6 ), each consisting of different subtypes. HCV genotypes and their subtypes coexist in various geographic locations but show different prevalence levels.